NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
-18.34%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.33B
AUM Growth
+$1.33B
(-18%)
Cap. Flow
+$6.16M
Cap. Flow
% of AUM
0.46%
Top 10 Holdings %
Top 10 Hldgs %
73.79%
Holding
45
New
1
Increased
3
Reduced
4
Closed
4
Top Buys
| 1 |
TEM
Tempus AI, Inc. Class A Common Stock
TEM
|
$160M |
| 2 |
VRNA
Verona Pharma
VRNA
|
$6.89M |
| 3 |
Gossamer Bio
GOSS
|
$2.03M |
| 4 |
Korro Bio
KRRO
|
$605K |
Top Sells
| 1 |
DM
Desktop Metal, Inc.
DM
|
$53.6M |
| 2 |
Geron
GERN
|
$42.4M |
| 3 |
BuzzFeed
BZFD
|
$31.7M |
| 4 |
ZFOX
ZeroFox Holdings, Inc. Common Stock
ZFOX
|
$20.2M |
| 5 |
CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
|
$11.5M |
Sector Composition
| 1 | Healthcare | 85.63% |
| 2 | Consumer Staples | 6.93% |
| 3 | Technology | 6.18% |
| 4 | Communication Services | 0.8% |
| 5 | Industrials | 0.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Arcellx
ACLX
$3.85B
| $207M | 15.55% | 3,745,262 | – | – |
|
|
TEM
2
Tempus AI, Inc. Class A Common Stock
TEM
$13.2B
| $160M | 12.04% | +4,572,810 | New | +$160M |
|
3
Rhythm Pharmaceuticals
RYTM
$6.85B
| $119M | 8.99% | 2,909,956 | – | – |
|
4
Savara
SVRA
$567M
| $98.6M | 7.42% | 24,471,264 | – | – |
|
5
Coursera
COUR
$1.88B
| $92.1M | 6.93% | 12,867,769 | – | – |
|
6
CRISPR Therapeutics
CRSP
$4.71B
| $85.8M | 6.45% | 1,587,854 | – | – |
|
|
VRNA
7
Verona Pharma
VRNA
$9.16B
| $80.8M | 6.08% | 5,584,753 +476,190 | +9% | +$6.89M |
|
8
NextNav
NN
$2.37B
| $66.4M | 5% | 8,189,156 | – | – |
|
|
9
Korro Bio
KRRO
$217M
| $36.9M | 2.78% | 1,090,793 +17,857 | +2% | +$605K |
|
10
Trevi Therapeutics
TRVI
$883M
| $33.9M | 2.55% | 11,370,376 | – | – |
|
11
Monte Rosa Therapeutics
GLUE
$296M
| $28.8M | 2.16% | 7,692,298 | – | – |
|
12
CVRx
CVRX
$205M
| $28.4M | 2.14% | 2,370,542 | – | – |
|
13
Aurinia Pharmaceuticals
AUPH
$1.58B
| $22.7M | 1.71% | 3,969,834 | – | – |
|
14
Nkarta
NKTX
$151M
| $21.1M | 1.59% | 3,568,781 | – | – |
|
15
Black Diamond Therapeutics
BDTX
$157M
| $20.7M | 1.56% | 4,448,757 | – | – |
|
16
Celcuity
CELC
$2.17B
| $20.5M | 1.54% | 1,250,001 | – | – |
|
17
Phathom Pharmaceuticals
PHAT
$864M
| $20.2M | 1.52% | 1,960,169 | – | – |
|
|
ADAP
18
Adaptimmune Therapeutics
ADAP
$15.6M
| $16.7M | 1.25% | 17,079,778 | – | – |
|
|
19
Gossamer Bio
GOSS
$562M
| $16.3M | 1.23% | 18,093,034 +2,255,025 | +14% | +$2.03M |
|
20
NeueHealth
NEUE
$59.2M
| $14.8M | 1.12% | 2,726,917 | – | – |
|
|
21
Geron
GERN
$893M
| $11.8M | 0.89% | 2,776,409 -10,000,000 | -78% | -$42.4M |
|
|
RGLS
22
DELISTED
Regulus Therapeutics
RGLS
| $11.6M | 0.87% | 6,467,802 | – | – |
|
|
INZY
23
DELISTED
Inozyme Pharma
INZY
| $10.9M | 0.82% | 2,437,689 | – | – |
|
24
Oric Pharmaceuticals
ORIC
$994M
| $10.6M | 0.8% | 1,500,000 | – | – |
|
|
25
BuzzFeed
BZFD
$72.6M
| $10.6M | 0.8% | 3,833,473 -11,500,419 | -75% | -$31.7M |
|